1. Janda, WM, Knapp, JS. Neisseria and Moraxella catarrhalis. In: Murray, PR, Baron, EJ, Jorgensen, JH, Pfaller, MA, Yolken, RH eds. Manual of Clinical of Microbiology, 8th edn. Washington, DC: ASM Press, 2003 585, pp. –608.
2. Raja, NS, et al. Invasive meningococcal disease in the university of Malaya Medical Centre, Kuala Lumpur, Malaysia. Journal of Postgraduate Medicine 2006: 52: 23–29.
3. World Health Organization. Communicable Disease Department, WHO Regional Office for South East Asia. Meningococcal disease in India, Epidemic and Pandemic Alert response (EPR), CD Alert 2005.
4. Taha, MK, et al. Circumvention of herd immunity during an outbreak of meningococcal disease could be correlated to escape mutation in the porA gene of Neisseria meningitidis. Infection & Immunity 2001; 169: 1971–1973.
5. Manchanda, V, Gupta, S, Bhalla, P. Meningococcal disease: history, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention. Indian Journal of Medical Microbiology 2006; 24: 7–19.
6. Singhal, S, et al. Ciprofloxacin resistant Neisseria meningitidis, Delhi, India. Emerging Infectious Diseases 2007; 13: 1614–1616.
7. CDC. Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 1997; 46: RR-10.
8. Vazquez, JA, et al. Interlaboratory comparison of agar dilution and E test methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections. Antimicrobial Agents and Chemotherapy 2003; 47: 3430–3434.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document (M100-S16), Vol. 26, Clinical and Laboratory Standards Institute, 2007. Wayne, Pennsylvania.
10. Taha, MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. Journal of Clinical Microbiology 2000; 32: 855–857.
11. Newcombe, J, et al. PCR of peripheral blood for diagnosis of meningococcal disease. Journal of Clinical Microbiology 1996; 34: 1637–1640.
12. Borrow, RH, et al. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiology and Infection 1997; 118: 111–117.
13. Sachdeva, A, et al. Meningococcal disease – outbreak in Delhi. Indian Pediatrics 2005; 42: 547–555.
14. Tunkel, AR, et al. Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases 2004; 39: 1267–1284.
15. Van Duren, M, Brandtzaeg, P, Van Dermeer, JWM. Update on Meningococcal disease with emphasis on pathogenesis and clinical management. Clinical Microbiology Reviews 2000; 13: 144–166.
16. Periappuram, M, Taylor, MRH, Keane, CT. Rapid detection of meningococci from petechiae in acute meningococcal infection. Journal of Infection 1995; 31: 201–203.
17. Lodder, MC, et al. Prognostic indicators of the outcome of meningococcal disease: a study of 562 cases. Journal of Medical Microbiology 1996; 45: 16–20.
18. Reger, LE, Kunz, G. Neisseria meningitidis meningitis. The John Hopkins Microbiology Newsletter 2001; 20: 1–3.
19. Erdem, G, et al. False positive latex agglutination test with Neisseria meningitidis ACYW135 in a patient with intracranial dermoid. Pediatrics Infectious Disease Journal 1994; 13: 550–551.
20. D'Amato, RF, Hochstein, L, Fay, EA. False-positive latex agglutination test for Neisseria meningitidis groups A and Y povidone-iodine antiseptic contamination of cerebrospinal fluid. Journal of Clinical Microbiology 1990; 28: 2134–2135.
21. Olcen, P, et al. Culture diagnosis of meningococcal carriers: yield from different sites and influence of storage in transport medium. Journal of Clinical Pathology 1979; 32: 1222–1225.
22. Pollard, AJ, et al. Meningococcal disease in British Columbia. BC Medical Journal 2001; 43: 21–27.
23. Carrol, ED et al. Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Archives of Diseases in Childhood 2000; 83: 271–273.
24. Canada Communicable Disease Report. Neisseria meningitidis with decreased susceptibility to penicillin in Ontario, Canada 1997–2000 2001; 27: 1–4.
25. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document (M100-S15) Clinical and Laboratory Standards Institute, 2005. Wayne, Pennsylvania.
26. Ayyagari, A, Dubey, ML, Bhandari, SK. Sulphadiazine resistant strains of Neisseria meningitidis during an outbreak of meningococcal meningitis. Indian Journal of Medical Research 1987; 85: 249–252.
27. Basu, RN, Prasad, R, Ichhpujani, RL. Meningococcal meningitis in Delhi and other areas. Communicable Diseases Bulletin 1985; 2: 1.
28. Annapurna, ME, Bhave, GG, Mathur, M. An outbreak of meningitis caused by Neisseria meningitidis Group A. Journal of Communicable Diseases 1989; 21: 24–26.
29. Tapsall, JW, et al. Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994–1999. Pathology 2001; 33: 359–361.
30. Oppenheim, BA. Antibiotic resistance in Neisseria meningitidis. Clinical Infectious Diseases 1997; 24: S98–S101.
31. Abadi, FJ, Yakubu, DE, Pennington, TH. In vitro activities of meropenem and other antimicrobial agents against British meningococcal isolates. Chemotherapy 1999; 45: 253–257.
32. Jorgensen, JH, Crawford, SA, Fiebelkorn, KR. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents. Journal of Clinical Microbiology 2005; 43: 3162–3171.
33. Shultz, TR, Tapsall, JW, White, PA. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones. Antimicrobial Agents and Chemotherapy 2000; 44: 1116.
34. Rainbow, J, et al. Rifampin-resistant meningococcal disease. Emerging Infectious Diseases 2005; 11: 977–979.
35. Capoor, MR, et al. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin resistant Salmonella causing enteric fever. Journal of Medical Microbiology 2007; 56: 1490–1494.
36. Mehta, G, Goyal, R. Emerging fluoroquinolone resistance in Neisseria meningitidis in India: cause for concern. Journal of Antimicrobial Chemotherapy 2007; 59: 329–330.